( Korea:006280 )

News from GC Pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 20, 2018, 19:00 ET GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of...


Apr 27, 2018, 04:10 ET GC Pharma Reports Q1 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results...


Apr 16, 2018, 08:00 ET GC Pharma Marks 'World Haemophilia Day'

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, joins World Haemophilia Day; observed annually by...


Feb 13, 2018, 23:13 ET GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK)...


Feb 04, 2018, 21:46 ET GC Pharma Reports Full Year 2017 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results...